Zimmer Biomet's The Tether: Innovative Treatment for Scoliosis Receives FDA Approval

Zimmer Biomet’s The Tether: Innovative Treatment for Scoliosis Receives FDA Approval

Zimmer Biomet’s The Tether is a non-fusion spinal device designed to treat skeletally immature patients with progressive idiopathic scoliosis. The device received FDA approval through the humanitarian device exemption (HDE) pathway, marking the first approval order for a humanitarian use device in spinal pediatrics within the last 15 years. The Tether is a major breakthrough in scoliosis treatment, providing a fusion-less option for maintaining spine mobility and reaching full potential. Ghost Productions produced a story-driven character animation that tells the story of Tara’s mother and her research on different treatment options for scoliosis, ultimately finding The Tether. Zimmer Biomet is excited to partner with the Harms Study Group for a new clinical study to optimally monitor patient outcomes. The Tether embodies Zimmer Biomet’s mission to improve the quality of life for people around the world and represents a focused, shared purpose that can fundamentally change the way we approach treatment of diseases like scoliosis.